About Dyadic
The rich history of Dyadic represents a microcosm of how modern biotechnology is revolutionizing science, medicine, agriculture, and engineering to improve how we feed, fuel, and heal the world.
Going forward we intend to focus on the pharmaceutical industry which we have long believed is one of the most attractive opportunities in which to apply the C1 technology. We believe that the C1 technology platform has the potential to be a safe and efficient expression system to help pharmaceutical and biotech companies speed up the development and lower the cost of manufacturing biologic vaccines and drugs to bring more affordable treatments to a greater number of patients, while helping to ease the burden biologic drugs are having on patients and the global healthcare systems, but most importantly saving lives.
Our Science
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus porttitor urna ac ultrices ultricies. Morbi mi nibh, ullamcorper nec maximus sit amet, dapibus pellentesque sapien.
Our Pipeline / Area of Focus
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus porttitor urna ac ultrices ultricies. Morbi mi nibh, ullamcorper nec maximus sit amet, dapibus pellentesque sapien.
Our Partners
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus porttitor urna ac ultrices ultricies. Morbi mi nibh, ullamcorper nec maximus sit amet, dapibus pellentesque sapien.
Watch a short video by Dr. Albert Osterhaus
The full, two-day ZAPI Stakeholders Final Conference Web Meeting is available on our Media Center / Presentations page
World Health Organization
WHO virtual consultation on novel manufacturing technologies for monoclonal antibody production
Read More About This Event
